BMS signs ADC development deal with Munich-based biotech worth more than $1B
BeiGene's gastric cancer drug succeeds in late-stage trial
FDA green lights Roche's Polivy in first-line DLBCL
Fresh layoffs at Nektar Therapeutics as it drops lupus program
*please scroll down for all the latest news*
